rss
Sex Transm Infect 2008;84:386-389 doi:10.1136/sti.2008.030205
  • Epidemiology

Epidemiology of hepatitis B virus infection in truck drivers in Brazil, South America

  1. M A Matos1,
  2. R M Bringel Martins2,
  3. D D da Silva França1,
  4. G C Pessoni1,
  5. R C Ferreira2,
  6. M A D Matos1,
  7. S M Brunini1,
  8. A L N Junqueira1,
  9. M A dos Santos Carneiro2,
  10. S A Teles1
  1. 1
    Faculdade de Enfermagem, Universidade Federal de Goiás, Goiânia, Goiás, Brazil
  2. 2
    Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Goiás, Brazil
  1. Dr Sheila Araujo Teles, Rua T. 38, n. 1097, apto 201, S. Bueno, CEP: 74223–040, Goiânia-Goiás, Brazil; Sheila{at}fen.ufg.br
  • Accepted 20 June 2008
  • Published Online First 24 July 2008

Abstract

Objective: To investigate the epidemiology of hepatitis B virus (HBV) infection and viral genotypes in long distance truck drivers in Brazil.

Methods: We interviewed 641 long distance truck drivers to gather data on sociodemographics and risk factors and collected blood samples to test for HBV markers (HBsAg, anti-HBs and anti-HBc) by ELISA. HBsAg-positive samples were submitted to HBV DNA detection and genotyped.

Results: We found a global HBV prevalence of 18.9% (95% CI 15.9 to 22.2). Thirty truck drivers (4.7%) had only anti-HBs, suggesting that they had a previous HBV vaccination. More than 20 years in the profession, more than 15 days away from home and a history of sexual transmitted infections were independently and positivity associated with HBV markers. HBV DNA was detected in nine samples in which genotypes A (n = 5), D (n = 2) and F (n = 2) were found.

Conclusions: These findings confirm that truck drivers are at high risk for hepatitis B infection and highlight the importance of having a public health policy that addresses this population and is based on the characteristics of HBV acquisition and dissemination.

Footnotes

  • Funding: Research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq); Fundação de Apoio a Pesquisa/UFG (FUNAPE/UFG).

  • Competing interests: None.

  • Ethics approval: This study was approved by the Human and Animal Research Ethics Committee of the Hospital Materno-Infantil, Goiânia, Goiás.

  • Contributors: MAM is a co-investigator who contributed to the project’s conceptualisation and was responsible for all fields operations; RMBM is a co-investigator who contributed to the study’s research design, conducted the laboratory analysis and assisted with write up; DDSF is a co-investigator who contributed with fields operations and assisted with data analysis; GCP is a co-investigator who contributed with fields operations and assisted with data analysis; RCF is a co-investigator who conducted laboratory analysis and assisted with the write up; MADM is a co-investigator who conducted laboratory analysis and assisted with data analysis; SMB is co-investigator who contributed with fields operations and assisted with data analysis; ALNJ is co-investigator who contributed with fields operations and write up; MASC is a co-investigator who conducted laboratory analysis and assisted with the write up; SAT is the study principal investigator responsible for all aspects of the study.

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.